Japan related Press Releases
PerkinElmer and Leading Japan Universities Announce Results of Collaboration to Detect Contamination from Nuclear Crisis
Global leader in detection technologies helps researchers create new tests for radiation in water, soil and food, for safety and decontamination WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. Read more...
Ono Pharmaceutical Company Selects Medidata Rave as Enterprise EDC/CDM Solution
Standard Use of Rave by Japanese Specialty Pharma Across All Trials Will Streamline Research, Accelerate Decision Making and Help Expand Global Network NEW YORK & OSAKA, Japan--(BUSINESS WIRE)-- Read more...
Nuron Biotech Licenses HibTITER® Vaccine to Mitsubishi Tanabe Pharma Corporation for Japanese Market
EXTON, Pa.--(BUSINESS WIRE)-- Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has licensed its HibTITER® vaccine to Mitsubishi Tanabe Pharma Corporation (Head Read more...
9th Annual BIO Asia International Conference to Feature New Deal Models and Discuss the Future of Innovation in Asia
Biotechnology Industry Organization (BIO) Announces Programming for 2012 Event, to Be Held in Osaka, Japan WASHINGTON--(BUSINESS WIRE)-- The BIO Asia International Conference will feature industry Read more...
QIAGEN Receives Regulatory Approval in Japan for EGFR Companion Diagnostic to Guide Cancer Treatments
-- therascreen® EGFR Mutation Detection Kit RGQ approved in Japan, one of the leading markets for pairing diagnostics with drug therapies in personalized healthcareTOKYO and HILDEN, Germany, Jan. 10, Read more...
Aeterna Zentaris Partner, Yakult Honsha, Initiates Phase 1/2 Trial with Perifosine in Colorectal Cancer in Japan
Trial initiation to trigger milestone payment to Aeterna Zentaris QUÉBEC CITY, Jan. 3, 2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that its Read more...
Takeda and Affymax Provide Update on Peginesatide Commercialization Rights in Japan
OSAKA, Japan & PALO ALTO, Calif.--(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE:4502) and Affymax, Inc. (Nasdaq:AFFY) today announced that Takeda has decided not to commercialize Read more...
Celgene Announces New Drug Application Filing for REVLIMID in Japan
Celgene Announces New Drug Application Filing for REVLIMID® in Japan REVLIMID filing based on safety and efficacy results of two large, randomised pivotal Phase III trials, as well as specific Read more...
Shire Announces Opening of Office in Japan
Shire Announces Opening of Office in Japan TOKYO, Japan and CAMBRIDGE, Massachusetts, February 20 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty Read more...
Bristol-Myers Squibb and AstraZeneca Announce Expansion of Worldwide Collaboration to Develop and Commercialize Dapagliflozin
Bristol-Myers Squibb and AstraZeneca Announce Expansion of Worldwide Collaboration to Develop and Commercialize Dapagliflozin in Japan PRINCETON, N.J. & LONDON--(BUSINESS WIRE)--Bristol-Myers
Read more...Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
